3H-labelled RU 38486: characterization of binding sites in human uterine cytosol.
The behaviour of the antifertilizing synthetic steroid RU 38486 towards human uterine progestin receptor was investigated. RU 38486 competed in the same order of magnitude as progesterone for the [3H]R 5020 binding site of progestin receptor, whereas R 5020 was unable to compete against [3H]RU 38486. This apparent contradiction could be explained by means of HPLC-chromatography. HPLC-chromatography with an anion exchange column (MonoQ, Pharmacia, Uppsala, Sweden) showed that [3H]RU 38486 forms at least two stable complexes with uterine cytosol, on one hand with serum albumin, which presents almost 90% of bound radioactivity, and on the other hand with the two native progestin receptor forms, corresponding to 4 S and 8 S receptor forms in sucrose density gradient analysis. Whether reduced binding of salt-activated RU 38486 receptor complexes to DNA-cellulose is due to reduced activation is still uncertain and remains to be further investigated.
D000019:Abortifacient Agents / Q000378:metabolism*; D000021:Abortifacient Agents, Steroidal / Q000378:metabolism*; D001665:Binding Sites; D002499:Centrifugation, Density Gradient; D002851:Chromatography, High Pressure Liquid; D003600:Cytosol / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004963:Estrenes / Q000378:metabolism*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D015735:Mifepristone; D011506:Proteins / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D013696:Temperature; D013997:Time Factors; D014599:Uterus / Q000378:metabolism*
D000019:Abortifacient Agents; D000021:Abortifacient Agents, Steroidal; D004963:Estrenes; D011506:Proteins; D011980:Receptors, Progesterone; D015735:Mifepristone; D004247:DNA